🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Adriamycin (Doxorubicin), Docetaxel, Tamoxifen, Cyclophosphamid

Found 20 matching trials

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

PHASE3

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Terminated

Location

Clinique Claude Bernard

Start Date

2002-11

Trial ID

NCT00053911

Treatments Being Tested

anastrozole cyclophosphamide docetaxel epirubicin hydrochloride fluorouracil goserelin acetate tamoxifen citrate adjuvant therapy

Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer

PHASE2

RATIONALE: Drugs used in chemotherapy, such as epirubicin, cyclophosphamide...

Status

Completed

Location

Shikoku Cancer Center

Start Date

2006-01

Trial ID

NCT00379015

Treatments Being Tested

trastuzumab cyclophosphamide docetaxel epirubicin hydrochloride conventional surgery neoadjuvant therapy

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

PHASE2

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Completed

Location

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Start Date

1999-02

Trial ID

NCT00003953

Treatments Being Tested

filgrastim CMF regimen docetaxel doxorubicin hydrochloride tamoxifen citrate autologous bone marrow transplantation surgical procedure radiation therapy

Combination Chemotherapy in Treating Women With Resected Breast Cancer

PHASE2

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Unknown

Location

U.Z. Gasthuisberg

Start Date

2001-02

Trial ID

NCT00033683

Treatments Being Tested

CMF regimen cyclophosphamide docetaxel epirubicin hydrochloride fluorouracil methotrexate tamoxifen citrate adjuvant therapy radiation therapy

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

PHASE3

This is a global Phase III, two-arm, open-label, multicenter, randomized st...

Status

Completed

Location

Maryland Oncology Hematology

Start Date

2018-06-14

Trial ID

NCT03493854

Treatments Being Tested

Cyclophosphamide Doxorubicin Docetaxel Paclitaxel Pertuzumab IV FDC of Pertuzumab and Trastuzumab SC Trastuzumab IV Trastuzumab SC Surgery Post-operative Radiotherapy Hormone Therapy

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

PHASE3

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Completed

Location

Veterans Affairs Medical Center - Birmingham

Start Date

1999-11-16

Trial ID

NCT00004125

Treatments Being Tested

cyclophosphamide docetaxel doxorubicin hydrochloride paclitaxel tamoxifen citrate radiation therapy

Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)

The main goal of the study is to abandon breast surgery in patients with br...

Status

Recruiting

Location

Petr Krivorotko

Start Date

2019-10-08

Trial ID

NCT04293796

Treatments Being Tested

Vacuum-assisted biopsy

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

PHASE3

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Completed

Location

Huntsville Hospital System

Start Date

1995-12

Trial ID

NCT00002707

Treatments Being Tested

Cyclophosphamide Docetaxel Doxorubicin Tamoxifen

Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment

PHASE3

The purpose of the study is to evaluate the benefit of adjuvant chemotherap...

Status

Completed

Location

Clinique du Sud Luxembourg

Start Date

2012-04-12

Trial ID

NCT01564056

Treatments Being Tested

HORMONOTHERAPY CHEMOTHERAPY then HORMONOTHERAPY

A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer

PHASE3

This study will evaluate the pharmacokinetics, efficacy, and safety of the ...

Status

Completed

Location

Peking University People's Hospital

Start Date

2020-02-05

Trial ID

NCT04024462

Treatments Being Tested

Pertuzumab IV Trastuzumab IV Pertuzumab and Trastuzumab FDC SC Doxorubicin Cyclophosphamide Docetaxel Surgery Post-Operative Radiotherapy Hormone Therapy

Previous Next